{"id":"W4393989000","doi":"10.1158/1538-7445.am2024-ct169","title":"Abstract CT169: First-in-human, phase 1/2 study of GSK4524101, an oral DNA polymerase theta inhibitor (POLQi), alone or combined with the poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) niraparib in adults with solid tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"PARP inhibitor; Poly ADP ribose polymerase; Polymerase; Molecular biology; DNA; Chemistry; Biology; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001316192,0.001899852,0.00172423,0.0004457556,0.0004057082,0.00126105,0.001052377,0.001526826,0.01101203],"category_scores_gemma":[0.0005106007,0.0005410415,0.001506147,0.000386346,0.0009615651,0.0008998823,0.0004149264,0.003377489,0.001965846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001059091,"about_ca_system_score_gemma":0.002282596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002198,"about_ca_topic_score_gemma":0.003663958,"domain_scores_codex":[0.9996259,0.000132025,0.0000199928,0.00007836281,0.00004887241,0.00009476115],"domain_scores_gemma":[0.9995334,0.00004285357,0.00008081816,0.00004163846,0.00003322862,0.0002681203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.436177,0.1335205,0.005043659,0.004866014,0.002341213,0.0009641887,0.0004394191,0.002912536,0.1721202,0.001218053,0.02375203,0.2166452],"study_design_scores_gemma":[0.3096239,0.6529683,0.004708974,0.0001469105,0.0007213372,0.001033606,0.00009485185,0.0006479562,0.01563844,0.0003121967,0.01405961,0.00004386372],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.955649,0.01635806,0.002202319,0.001489432,0.0008031027,0.007734579,0.007089081,0.0004136259,0.008260889],"genre_scores_gemma":[0.9422809,0.01211818,0.004931819,0.00323481,0.0005673458,0.006029846,0.009366436,0.0001307506,0.0213399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01101203,"threshold_uncertainty_score":0.03683895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0650436417362831,"score_gpt":0.4188500716926601,"score_spread":0.353806429956377,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}